Open Date
07 Nov 2023
09 Nov 2023
1600 shares
₹10.85 Cr
Lot Size
IPO Size
Listing At
NSE SME
Listing Date
Price Range
₹84 per share
Close Date
Allotment Date
15 Nov 2023
20 Nov 2023
Sunrest Lifescience Limited, founded in 2017, provides a wide range of healthcare and personal care goods. Sunrest Lifescience's product portfolio includes anti-bacterial, anti-diarrheal, anti-fungal, anti-malerial, anti-diabetic, anti-diabetic, dental cure, anti-protozol, anti-histamine, anti-hypertensive drugs, cosmetic, anti-parasitic, multivitamin, multimineral, nutraceutical, and anti-inflammatory drugs. Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste are among the products available from the firm.
The Issue Proceeds from the Fresh Issue will be utilized towards the following objects: 1. Meeting Working Capital Requirements 2. General Corporate Purpose 3. Meeting Public Issue Expenses
The book-running lead managers to the offer are: Mark Corporate Advisors Private Ltd
Disclaimer Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.